| CXHL1700350 | 万格列净 | | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-01-31 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2018-01-29 | view |
| CXHL1700351 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXHL1700353 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXHL1700352 | 万格列净片 | | Tablet | Chemical Drugs(1) | New Drug Application | 2018-02-07 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2018-07-06 | view |
| CXSL1700210 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(10) | New Drug Application | 2018-02-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2018-02-12 | view |
| CXSL1700209 | 利拉鲁肽 | liraglutide | Active ingredient | Biological Products(10) | New Drug Application | 2018-02-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2018-02-12 | view |
| CYHS1800084 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs(4) | Generic Drug | 2018-05-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-01-26 | view |
| CYHB1850043 | 格列美脲片 | glimepiride | Tablet | Chemical Drugs | Supplementary Application | 2018-05-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2019-01-25 | view |
| CYHB1850042 | 格列美脲片 | glimepiride | Tablet | Chemical Drugs | Supplementary Application | 2018-05-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2019-01-25 | view |
| CYHS1800090 | 阿哌沙班片 | apixaban | Tablet | Chemical Drugs(4) | Generic Drug | 2018-05-25 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-02-05 | view |
| CYHS1900393 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2019-06-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-02-05 | view |
| CYHB1950416 | 匹伐他汀钙片 | pitavastatin calcium | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-22 | view |
| CYHB1950415 | 匹伐他汀钙片 | pitavastatin calcium | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-22 | view |
| CYHB1950424 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2019-06-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-16 | view |
| CYHB1950425 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2019-06-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-16 | view |
| CYHS1900781 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs(4) | Generic Drug | 2019-11-20 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2019-11-19 | view |
| CYHS1900797 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs(4) | Generic Drug | 2019-11-23 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-01-26 | view |
| CXSL1900149 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(7) | New Drug Application | 2019-12-26 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2019-12-25 | view |
| CYHB2050015 | 替米沙坦片 | telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2020-01-16 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-12-21 | view |
| CYSB2000033 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-03-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-12-15 | view |
